Category Archive for: Prescription Drugs

Actos Side Effects

What is Actos®? Actos (pioglitazone) is an oral anti-diabetic prescription drug used to help regulate blood sugar for the treatment in adults of Type 2 diabetes. Since its introduction in 1999, Actos has been surrounded by continuing controversy stemming from numerous allegations pointing out to an association with a risk of bladder cancer. Failing to […]

Side Effects of Risperdal

Justice for Victims of Risperdal Side Effects The pharmaceutical giant Johnson & Johnson has recently been ordered to pay $2.2 billion in health care fraud settlements due to illegal marketing tactics of the drugs Risperdal, Invega and Natrecor. Ortho-McNeil-Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, pled guilty to charges that sales reps illegally promoted […]

Filing a Dialysis Heart Attack Lawsuit

When Filing a Dialysis Heart Attack Lawsuit You Could Receive Compensation Fresenius Medical Care, which operates clinics that treat about one-third of the nearly 400,000 dialysis patients in the U.S., is facing dialysis heart attack lawsuits. Non Fresenius-operated clinics could also be at risk because Fresenius Medical Care is also the largest supplier of products to other dialysis […]

First Byetta Lawsuit Goes to Trial in November

Byetta Lawsuit Warning Since 2007, the FDA and numerous medical studies have issued warnings about the link between the diabetes drug Byetta and pancreatitis, as well as several other serious health conditions. Consequently, a growing number of lawsuits have been filed across the U.S. – the first of which will go to trial in Los […]

Byetta Cancer. Did Manufacturers Know About Potential Health Risks?

When Did Manufacturers Know About Byetta Cancer Health Risks? Claims that Amylin Pharmaceuticals and Eli Lilly failed to communicate the potential risk of pancreatic Byetta cancer, are nearing the pre-trial phase. The reality of the risk is evident in stories like that of Rebecca Richard, who filed a claim on behalf of her deceased husband, David, who […]

Did Fresenius Withhold Knowledge of GranuFlo Side Effects?

What are GranuFlo Side Effects? Granuflo. Aside from hearing it mentioned during just about every other commercial break, there probably isn’t much else you know about it. That’s because it’s one of several chemicals used in dialysis. The U.S. Food and Drug Administration (FDA) approved Granuflo in 2003. It’s manufactured by Fresenius Medical Care (FMC), […]

New Cases of Januvia Cancer Trigger More Lawsuits

Januvia is the latest Type 2 diabetes drug to receive national attention due to its serious side effects. The development of Januvia cancer among patients has spawned a growing number of lawsuits against Merck & Co., the maker and marketer of the drug. The following include some the latest updates on Januvia warnings and Januvia […]

Study Links Pradaxa Bleeding in Patients Taking Medicine

Pradaxa News: Research Reveals Pradaxa Bleeding in Patients Taking Medicine When Pradaxa was approved by the FDA in 2010, it was touted as a safer alternative to other blood thinning medications, which help prevent strokes. But just one year later, the drug was linked to more deaths in the U.S. than any other prescription medication. […]

Avandia Settlement: GlaxoSmithKline Could Pay Up to $6 Billion in Lawsuits

How Much Will My Avandia Settlement Be? After a two-year investigation by the U.S. Senate Finance Committee revealed that GlaxoSmithKline, the maker of Avandia, intentionally suppressed information about the drug’s link to heart attacks, tens of thousands of lawsuits have been filed in the U.S. alone. The first signs of trouble started in 2007, when the […]

First Actos Lawsuit to Be Decided in California

Historical Actos Lawsuit in California In early March, the first Actos trial went to court in Los Angeles. The plaintiffs, John and Nancy Cooper, filed an Actos lawsuit in 2012 against Takeda Pharmaceuticals (the makers of Actos), alleging that Jack’s severe bladder cancer resulted from taking the diabetes drug Actos for more than two years. […]